Researchers explore the prospective link between screen time and the risk of developing dementia, Parkinson’s disease, and depression.
Second Drug for Geographic Atrophy Gets Green Light From FDA
The FDA approved avacincaptad pegol (Izervay) for geographic atrophy secondary to age-related macular degeneration (AMD), Iveric Bio announced. A complement C5 inhibitor, avacincaptad pegol significantly